Gruber M, Bozic I, Leshchiner I, et al. Growth dynamics in naturally progressing chronic lymphocytic leukaemia. Nature. 2019;570(7762):474-479. doi:10.1038/s41586-019-1252-x
Publications
Flannick J, Mercader JM, Fuchsberger C, et al. Exome sequencing of 20,791Â cases of type 2 diabetes and 24,440Â controls. Nature. 2019;570(7759):71-76. doi:10.1038/s41586-019-1231-2
Yim SH, Clish CB, Gladyshev VN. Selenium Deficiency Is Associated with Pro-longevity Mechanisms. Cell Rep. 2019;27(9):2785-2797.e3. doi:10.1016/j.celrep.2019.05.001
Flentie K, Harrison GA, Tükenmez H, et al. Chemical disarming of isoniazid resistance in . Proc Natl Acad Sci U S A. 2019;116(21):10510-10517. doi:10.1073/pnas.1818009116
Schmidt K, Carroll JS, Yee E, et al. The lncRNA SLNCR Recruits the Androgen Receptor to EGR1-Bound Genes in Melanoma and Inhibits Expression of Tumor Suppressor p21. Cell Rep. 2019;27(8):2493-2507.e4. doi:10.1016/j.celrep.2019.04.101
Huang TP, Zhao KT, Miller SM, et al. Circularly permuted and PAM-modified Cas9 variants broaden the targeting scope of base editors. Nat Biotechnol. 2019. doi:10.1038/s41587-019-0134-y
Struntz NB, Chen A, Deutzmann A, et al. Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription. Cell Chem Biol. 2019;26(5):711-723.e14. doi:10.1016/j.chembiol.2019.02.009
Price C, Gill S, Ho ZV, et al. Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers. Cancer Res. 2019;79(10):2564-2579. doi:10.1158/0008-5472.CAN-18-2674
Maianti JP, Tan GA, Vetere A, et al. Substrate-selective inhibitors that reprogram the activity of insulin-degrading enzyme. Nat Chem Biol. 2019. doi:10.1038/s41589-019-0271-0
Chan MM, Smith ZD, Grosswendt S, et al. Molecular recording of mammalian embryogenesis. Nature. 2019. doi:10.1038/s41586-019-1184-5